Skip to main content
PMC home page
Bulletin of the World Health Organization logoLink to Bulletin of the World Health Organization
. 1971;44(1-2-3):289–307.

Cholinesterase inhibition by organophosphorus compounds and its clinical effects*

Tatsuji Namba
PMCID: PMC2428032  PMID: 4941660

Abstract

The clinical manifestations of acute poisoning by organophosphorus compounds in man are in accord with, initially, the stimulation and, later, the blocking of cholinergic transmission due to acetylcholinesterase inhibition. The manifestations involve mainly the para-sympathetic nerves, the neuromuscular junctions, and the central nerve synapses, and to a smaller degree the cholinergic sympathetic nerves. Miosis and muscle fasciculations are useful signs for diagnosis and for the control of therapy. Blood cholinesterase determination is the best diagnostic test. The cause of death is usually respiratory paralysis. Persistent manifestations have not been confirmed. Atropine and pralidoxime are effective for treatment and useful for diagnosis. Other oximes are promising but their clinical value has not been established. Poisoning by malathion is characterized by a prolonged course and by motor signs. Poisoning by organophosphorus compounds in man differs from animal experiments in several ways: in man, exposure may occur by several different routes, the manifestations are detected more easily, and therapy is given throughout the course of illness.

Full text

PDF
289

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BISA K., FISCHER G., MUELLER O., OLDIGES H., ZOCH E. DIE ANTIDOTWIRKUNG VON BIS- Arzneimittelforschung. 1964 Feb;14:85–88. [PubMed] [Google Scholar]
  2. Barckow D., Neuhaus G., Erdmann W. D. Zur Behandlung der schweren Parathion-(E 605)-Vergiftung mit dem Cholinesterase-Reaktiver Obidoxim (Toxogonin) Arch Toxikol. 1969;24(2):133–146. [PubMed] [Google Scholar]
  3. Boelcke G., Butigan N., Davar H., Erdmann W. D., Gaaz J. W., Nenner M. Neue Erfahrungen bei der toxikologisch kontrollierten Therapie einer ungewöhnlich schweren Vergiftung mit Nitrostigmin (E 605 forte) Dtsch Med Wochenschr. 1970 Dec 11;95(50):2516–2521. doi: 10.1055/s-0028-1108867. [DOI] [PubMed] [Google Scholar]
  4. Boelcke G., Creutzfeldt W., Erdmann W. D., Gaaz J. W., Jacob G. Untersuchungen zur Frage der Lebertoxizität von Obidoxim (Toxogonin) am Menschen. Dtsch Med Wochenschr. 1970 May 22;95(21):1175–1178. doi: 10.1055/s-0028-1108609. [DOI] [PubMed] [Google Scholar]
  5. Boelcke G., Erdmann W. D. Der Einfluss der E 605-Vergiftung und der spezifischen Antidot-Therapie auf die Leberfunktion des Kaninchens. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol. 1969;263(1):198–199. [PubMed] [Google Scholar]
  6. Boelcke G., Gaaz J. W. Zur Frage der Lebertoxicität von Nitrostigmin (E 605 forte) und Obidoxim (Toxogonin) an Hunden. Arch Toxikol. 1970;26(2):93–101. [PubMed] [Google Scholar]
  7. Boffey P. M. Nerve gas. Dugway accident linked to Utah sheep kill. Science. 1968 Dec 27;162(3861):1460–1464. doi: 10.1126/science.162.3861.1460. [DOI] [PubMed] [Google Scholar]
  8. CLITHEROW J. W., MITCHARD M., HARPER N. J. THE POSSIBLE BIOLOGICAL FUNCTION OF PSEUDOCHOLINESTERASE. Nature. 1963 Sep 7;199:1000–1001. doi: 10.1038/1991000a0. [DOI] [PubMed] [Google Scholar]
  9. Calesnick B., Christensen, Richter M. Human toxicity of various oximes. 2-Pyridine aldoxime methyl chloride, its methane sulfonate salt, and 1,1'-trimethylenebis-(4-formylpyridinium chloride). Arch Environ Health. 1967 Nov;15(5):599–608. doi: 10.1080/00039896.1967.10664975. [DOI] [PubMed] [Google Scholar]
  10. DALY M. D., WRIGHT P. G. The effects of anticholinesterases upon peripheral vascular resistance in the dog. J Physiol. 1956 Sep 27;133(3):475–497. doi: 10.1113/jphysiol.1956.sp005603. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. DEROETTH A., Jr, DETTBARN W. D., ROSENBERG P., WILENSKY J. G., WONG A. EFFECT OF PHOSPHOLINE IODIDE ON BLOOD CHOLINESTERASE LEVELS OF NORMAL AND GLAUCOMA SUBJECTS. Am J Ophthalmol. 1965 Apr;59:586–592. [PubMed] [Google Scholar]
  12. DIRNHUBER P., CULLUMBINE H. The effect of anti-cholinesterase agents on the rat's blood pressure. Br J Pharmacol Chemother. 1955 Mar;10(1):12–15. doi: 10.1111/j.1476-5381.1955.tb00052.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. DUBOIS K. P. Insecticides, rodenticides, herbicides; household hazards. Postgrad Med. 1958 Sep;24(3):278–288. doi: 10.1080/00325481.1958.11692212. [DOI] [PubMed] [Google Scholar]
  14. DURHAM W. F., HAYES W. J., Jr Organic phosphorus poisoning and its therapy. With special reference to modes of action and compounds that reactivate inhibited cholinesterase. Arch Environ Health. 1962 Jul;5:21–47. doi: 10.1080/00039896.1962.10663237. [DOI] [PubMed] [Google Scholar]
  15. Dustman E. H., Stickel L. F. The occurrence and significance of pesticide residues in wild animals. Ann N Y Acad Sci. 1969;160(1):162–172. doi: 10.1111/j.1749-6632.1969.tb15837.x. [DOI] [PubMed] [Google Scholar]
  16. ELLIN R. I., WILLS J. H. OXIMES ANTAGONISTIC TO INHIBITORS OF CHOLINESTERASE. II. J Pharm Sci. 1964 Oct;53:1143–1150. doi: 10.1002/jps.2600531002. [DOI] [PubMed] [Google Scholar]
  17. ERDMANN W. D., BOSSE I., FRANKE P. ZUR RESORPTION UND AUSSCHEIDUNG VON TOXOGONIN NACH INTRAMUSKULAERER INJEKTION AM MENSCHEN. Dtsch Med Wochenschr. 1965 Aug 13;90:1436–1438. doi: 10.1055/s-0028-1113353. [DOI] [PubMed] [Google Scholar]
  18. ERDMANN W. D., ENGELHARD H. PHARMAKOLOGISCH-TOXIKOLOGISCHE UNTERSUCHUNGEN MIT DEM DICHLORID DES BIS- Arzneimittelforschung. 1964 Jan;14:5–11. [PubMed] [Google Scholar]
  19. ERDMANN W. D. VERGLEICHENDE UNTERSUCHUNGEN UEBER DAS PENETRATIONSVERMOEGEN EINIGER ESTERASEREAKTIVIERENDER OXIME IN DAS ZENTRALE NERVENSYSTEM. Arzneimittelforschung. 1965 Feb;15:135–139. [PubMed] [Google Scholar]
  20. ERDMANN W. D., VON CLARMANN EIN NEUER ESTERASE-REAKTIVATOR FUER DIE BEHANDLUNG VON VERGIFTUNGEN MIT ALKYLPHOSPHATEN. Dtsch Med Wochenschr. 1963 Nov 8;88:2201–2206. doi: 10.1055/s-0028-1112348. [DOI] [PubMed] [Google Scholar]
  21. Erdmann W. D. Antidotbehandlung bei Alkylphosphatvergiftungen. Arch Toxikol. 1968;24(1):30–40. [PubMed] [Google Scholar]
  22. FROST J., POULSEN E. POISONING DUE TO PARATHION AND OTHER ORGANOPHOSPHORUS INSECTICIDES IN DENMARK. Dan Med Bull. 1964 Oct;11:169–177. [PubMed] [Google Scholar]
  23. Falb A., Erdmann W. D. Uber die Permeation von 14C-Obidoxim durch die sog. Blut-Hirnschranke von Mäusen und Ratten. Arch Toxikol. 1969;24(2):123–132. [PubMed] [Google Scholar]
  24. GERSHON S., SHAW F. H. Psychiatric sequelae of chronic exposure to organophosphorus insecticides. Lancet. 1961 Jun 24;1(7191):1371–1374. doi: 10.1016/s0140-6736(61)92004-9. [DOI] [PubMed] [Google Scholar]
  25. GIARMAN N. J., PEPEU G. Drug-induced changes in brain acetylcholine. Br J Pharmacol Chemother. 1962 Oct;19:226–234. doi: 10.1111/j.1476-5381.1962.tb01184.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. GOLZ H. H. Controlled human exposures to malathion aerosols. AMA Arch Ind Health. 1959 May;19(5):516–523. [PubMed] [Google Scholar]
  27. HAYES W. J., Jr, MATTSON A. M., SHORT J. G., WITTER R. F. Safety of malathion dusting powder for louse control. Bull World Health Organ. 1960;22:503–514. [PMC free article] [PubMed] [Google Scholar]
  28. HEILBRONN E., TOLAGEN B. TOXOGONIN IN SARIN, SOMAN AND TABUN POISONING. Biochem Pharmacol. 1965 Jan 1;14:73–77. doi: 10.1016/0006-2952(65)90059-6. [DOI] [PubMed] [Google Scholar]
  29. HODGKIN W., GIBLETT E. R., LEVINE H., BAUER W., MOTULSKY A. G. COMPLETE PSEUDOCHOLINESTERASE DEFICIENCY: GENETIC AND IMMUNOLOGIC CHARACTERIZATION. J Clin Invest. 1965 Mar;44:486–493. doi: 10.1172/JCI105162. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. HOLMSTEDT B., LUNDGREN G., SUNDWALL A. TREMORINE AND ATROPINE EFFECTS ON BRAIN ACETYLCHOLINE. Life Sci. 1963 Oct;10:731–736. doi: 10.1016/0024-3205(63)90077-8. [DOI] [PubMed] [Google Scholar]
  31. HORNYKIEWICZ O., KOBINGER W. Uber den Einfluss von Eserin, Tetraäthylpyrophosphat (TEPP) und Neostigmin auf den Blutdruck und die pressorischen Carotissinusreflexe der Ratte. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol. 1956;228(5):493–500. [PubMed] [Google Scholar]
  32. HUMPERDINCK K. Gewerbliche Schädigung durch E 605? Med Klin. 1951 Jun 22;46(25-26):719–721. [PubMed] [Google Scholar]
  33. Harris C. J., Williford E. A., Kemberling S. R., Morgan D. P. Pesticide intoxications in Arizona. Ariz Med. 1969 Nov;26(11):872–876. [PubMed] [Google Scholar]
  34. Himmel G., Sterz H. Vorhofflimmern bei Alkylphosphatvergiftung. Wien Klin Wochenschr. 1968 May 3;80(18):350–351. [PubMed] [Google Scholar]
  35. JAGER B. V., STAGG G. N. Toxicity of diacetyl monoxime and of pyridine-2-aldoxime methiodide in man. Bull Johns Hopkins Hosp. 1958 Apr;102(4):203–211. [PubMed] [Google Scholar]
  36. Klemm D., Blümchen G., Pfannenstiel P., Vogel W., Beck K. Cholostatische Hepatose nach Toxogoninbehandlung bei einem Fall von Alkylphosphatvergiftung. Med Klin. 1968 Jan 19;63(3):94–96. [PubMed] [Google Scholar]
  37. Knolle J. Suicidal Vergiftung durch subcutane Injektion eines Gemisches von Parathion und Demeton-o-methylsulfoxid (E 605 MR) Arch Toxikol. 1970;26(1):29–39. [PubMed] [Google Scholar]
  38. Kunstling T. R., Rosse W. F. Erythrocyte acetylcholinesterase deficiency in paroxysmal nocturnal hemoglobinuria (PNH). A comparison of the complement-sensitive and insensitive populations. Blood. 1969 Apr;33(4):607–616. [PubMed] [Google Scholar]
  39. Lipson M. L., Holmes J. H., Ellis P. P. Oral administration of pralidoxime chloride in echothiophate iodide therapy. Arch Ophthalmol. 1969 Dec;82(6):830–835. doi: 10.1001/archopht.1969.00990020822019. [DOI] [PubMed] [Google Scholar]
  40. MOELLER H. C., RIDER J. A. Plasma and red blood cell cholinesterase activity as indications of the threshold of incipient toxicity of ethyl-p-nitrophenyl thionobenzenephosphonate (EPN) and malathion in human beings. Toxicol Appl Pharmacol. 1962 Jan;4:123–130. doi: 10.1016/0041-008x(62)90081-9. [DOI] [PubMed] [Google Scholar]
  41. Mathewson I., Hardy E. A. Treatment of malathion poisoning. Experience of two cases in Sarawak. Anaesthesia. 1970 Apr;25(2):265–271. doi: 10.1111/j.1365-2044.1970.tb00197.x. [DOI] [PubMed] [Google Scholar]
  42. Milosević M. P. Acetylcholine content in the brain of rats treated with paraoxon and obidoxime. Br J Pharmacol. 1970 Aug;39(4):732–737. doi: 10.1111/j.1476-5381.1970.tb09899.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Milosević M. P. Acetylcholine content in the brain of rats treated with paraoxon and pyridinium-2-aldoxime methylchloride. J Pharm Pharmacol. 1969 Jul;21(7):469–470. doi: 10.1111/j.2042-7158.1969.tb08290.x. [DOI] [PubMed] [Google Scholar]
  44. Mootoo C. L., Singh B. Review of 210 deaths by poisoning in British Guiana (1959-1964). West Indian Med J. 1966 Mar;15(1):11–17. [PubMed] [Google Scholar]
  45. Murphy S. D., Lauwerys R. R., Cheever K. L. Comparative anticholinesterase action of organophosphorus insecticides in vertebrates. Toxicol Appl Pharmacol. 1968 Jan;12(1):22–35. doi: 10.1016/0041-008x(68)90172-5. [DOI] [PubMed] [Google Scholar]
  46. Murphy S. D. Malathion inhibition of esterases as a determinant of malathion toxicity. J Pharmacol Exp Ther. 1967 May;156(2):352–365. [PubMed] [Google Scholar]
  47. NAMBA T., HIRAKI K. PAM (pyridine-2-aldoxime methiodide) therapy for alkyl-phosphate poisoning. J Am Med Assoc. 1958 Apr 12;166(15):1834–1839. doi: 10.1001/jama.1958.02990150030007. [DOI] [PubMed] [Google Scholar]
  48. Namba T., Greenfield M., Grob D. Malathion poisoning. A fatal case with cardiac manifestations. Arch Environ Health. 1970 Oct;21(4):533–541. doi: 10.1080/00039896.1970.10667285. [DOI] [PubMed] [Google Scholar]
  49. Namba T., Grob D. Cholinesterase activity of motor end plate in human skeletal muscle. J Clin Invest. 1970 May;49(5):936–942. doi: 10.1172/JCI106313. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Namba T., Nolte C. T., Jackrel J., Grob D. Poisoning due to organophosphate insecticides. Acute and chronic manifestations. Am J Med. 1971 Apr;50(4):475–492. doi: 10.1016/0002-9343(71)90337-8. [DOI] [PubMed] [Google Scholar]
  51. O'LEARY J. F., KUNKEL A. M., JONES A. H. Efficacy and limitations of oxime-atropine treatment of organophosphorus anticholinesterase poisoning. J Pharmacol Exp Ther. 1961 Apr;132:50–57. [PubMed] [Google Scholar]
  52. PAULET G. Nouvelle contribution à l'étude de l'action pharmacologique du tétraéthylpyrophosphate (TEPP). Arch Int Pharmacodyn Ther. 1954 Mar;97(2):157–185. [PubMed] [Google Scholar]
  53. POLET H., DE SCHAEPDRYVER A. F. Effect of sarin on the cardio-inhibitory, vasomotor and respiratory centers of the isolated head in dogs. Arch Int Pharmacodyn Ther. 1959 Jan 1;118(1-2):231–247. [PubMed] [Google Scholar]
  54. Prinz H. J. Eine schwere percutane Vergiftung mit Parathion (E 605) Arch Toxikol. 1969;24(3):318–328. [PubMed] [Google Scholar]
  55. Quinby G. E. Feasibility of prophylaxis by oral pralidoxime. Cholinesterase inactivation by organophosphorus pesticides. Arch Environ Health. 1968 Jun;16(6):812–820. doi: 10.1080/00039896.1968.10665158. [DOI] [PubMed] [Google Scholar]
  56. RICHARDS A. G. MALATHION POISONING SUCCESSFULLY TREATED WITH LARGE DOSES OF ATROPINE. Can Med Assoc J. 1964 Jul 11;91:82–83. [PMC free article] [PubMed] [Google Scholar]
  57. Reich G. A., Berner W. H. Aerial application accidents 1963 to 1966. An analysis of the principal factors. Arch Environ Health. 1968 Nov;17(5):776–784. doi: 10.1080/00039896.1968.10665319. [DOI] [PubMed] [Google Scholar]
  58. Reich G. A., Davis J. H., Davies J. E. Pesticide poisoning in south Florida. An analysis of mortality and morbidity and a comparison of sources of incidence data. Arch Environ Health. 1968 Nov;17(5):768–775. doi: 10.1080/00039896.1968.10665318. [DOI] [PubMed] [Google Scholar]
  59. STAUDACHER H. L. ERFOLGREICHE BHANDLUNG EINER E-605-VERGIFTUNG MIT EINEM NEUEN CHOLINESTERASE-REAKTIVATOR. Arztl Forsch. 1963 Aug 10;17:441–443. [PubMed] [Google Scholar]
  60. Sidell F. R., Groff W. A., Ellin R. I. Blood levels of oxime and symptoms in humans after single and multiple oral doses of 2-pyridine aldoxime methochloride. J Pharm Sci. 1969 Sep;58(9):1093–1098. doi: 10.1002/jps.2600580911. [DOI] [PubMed] [Google Scholar]
  61. Simson R. E., Simpson G. R., Penney D. J. Poisoning with monocrotophos, an organophosphorus pesticide. Med J Aust. 1969 Nov 15;2(20):1013–1016. doi: 10.5694/j.1326-5377.1969.tb107562.x. [DOI] [PubMed] [Google Scholar]
  62. Singh S., Balkrishan, Malhotra V. Parathion poisoning in Punjab (a clinical and electrocardiographic study of 20 cases). J Assoc Physicians India. 1969 Mar;17(3):181–187. [PubMed] [Google Scholar]
  63. Stoeckel H., Meinecke K. H. Uber eine gewerbliche Vergiftung durch Mevinphos. Arch Toxikol. 1966;21(5):284–288. [PubMed] [Google Scholar]
  64. WILLS J. H. Recent studies of organic phosphate poisoning. Fed Proc. 1959 Dec;18:1020–1025. [PubMed] [Google Scholar]
  65. WILSON I. B., GINSBURG B. A powerful reactivator of alkylphosphate-inhibited acetylcholinesterase. Biochim Biophys Acta. 1955 Sep;18(1):168–170. doi: 10.1016/0006-3002(55)90040-8. [DOI] [PubMed] [Google Scholar]
  66. Wender M., Owsianowski M. On a successfully treated acute oral paraoxone (E 600) poisoning. Arch Toxikol. 1969;24(3):329–332. [PubMed] [Google Scholar]
  67. Wilson B. W., Stinnett H. O. Growth and respiration of monolayer cell cultures of chick embryo heart and skeletal muscle: action of malathion and malaoxon. Proc Soc Exp Biol Med. 1969 Jan;130(1):30–34. doi: 10.3181/00379727-130-33481. [DOI] [PubMed] [Google Scholar]
  68. Zavon M. R., Tye R., Latorre L. Chlorinated hydrocarbon insecticide content of the neonate. Ann N Y Acad Sci. 1969;160(1):196–200. doi: 10.1111/j.1749-6632.1969.tb15840.x. [DOI] [PubMed] [Google Scholar]
  69. Zech R., Erdmann W. D., Engelhard H. Grenzen der Therapie mit Oximen bei Vergiftungen mit insekticiden Alkylphosphaten. Arzneimittelforschung. 1967 Sep;17(9):1196–1202. [PubMed] [Google Scholar]
  70. von Clarmann M., Geldmacher-von Mallinck Uber eine erfolgreich behandelte akute orale Vergiftung durch Fenthion und dessen Nachweis in Mageninhalt und Harn. Arch Toxikol. 1966;22(1):2–11. [PubMed] [Google Scholar]
  71. von KAULLA, HOLMES J. H. Changes following anticholinesterase exposures. Blood coagulation studies. Arch Environ Health. 1961 Feb;2:168–177. doi: 10.1080/00039896.1961.10662831. [DOI] [PubMed] [Google Scholar]

Articles from Bulletin of the World Health Organization are provided here courtesy of World Health Organization

RESOURCES